JS

Jim Sullivan

Chief Executive Officer

Chamishi

Chicago, Illinois


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Chamishi
Industry
research
Employees
33.0
Seniority
C suite
Annual Revenue
780000.0
Total Funding
130000000.0
Latest Funding
Series B

Technologies

Outlook Microsoft Office 365 DigitalOcean WordPress.org Google Font API Mobile Friendly Google Tag Manager Ubuntu Apache Remote Circle Proofpoint

Keywords

biotechnology research neurodegeneration biopharmaceutical drug development gcase parkinson's disease alzheimer's disease dementia with lewy bodies therapeutics clinical development neuronal pathways innate immune system small molecule brain-penetrant allosteric activator gba1 gene lysosomal biology neuroinflammation gcase activators patient-derived cells therapeutic hypothesis disease-modifying therapies phase 1 clinical trial c5ar1 antagonism neurodegenerative diseases transformative medicines therapeutic targets biotech drug discovery chronic disorders treatment paradigms biomedical research immune response clinical trials scientific partnerships drug efficacy pathological proteins molcular biology patient care drug candidates innovative therapies neurobiology scientific expertise patient-centric chemical compounds disease progression enzyme activation healthcare innovation research collaborations therapeutic interventions market opportunities health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans